Filing Details
- Accession Number:
- 0001179110-12-006972
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-19 19:10:56
- Reporting Period:
- 2012-04-17
- Filing Date:
- 2012-04-19
- Accepted Time:
- 2012-04-19 18:10:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820237 | Gen Probe Inc | GPRO | Surgical & Medical Instruments & Apparatus (3841) | 330044608 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1205465 | Carl Hull | Gen-Probe Incorporated 10210 Genetic Center Drive San Diego CA 92121 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-04-17 | 7,083 | $47.42 | 54,050 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-04-17 | 5,883 | $66.23 | 48,167 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-04-17 | 1,200 | $66.65 | 46,967 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-04-17 | 7,083 | $0.00 | 7,083 | $47.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 62,188 | 2014-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2011.
- This transaction was executed in multiple trades at prices ranging from $65.61 to $66.60. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the reported transactions were effected.
- This transaction was executed in multiple trades at prices ranging from $66.61 to $66.675. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the reported transactions were effected.
- The shares subject to the stock option vested and became fully exercisable as of March 1, 2011.
Billionaire Hedge Funds
